Cell Death and Disease (Oct 2022)

Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1

  • Christine Engelmann,
  • Patrick Schuhmachers,
  • Hana Zdimerova,
  • Sanamjeet Virdi,
  • Mathias Hauri-Hohl,
  • Jana Pachlopnik Schmid,
  • Adam Grundhoff,
  • Rebecca A. Marsh,
  • Wendy Wei-Lynn Wong,
  • Christian Münz

DOI
https://doi.org/10.1038/s41419-022-05337-z
Journal volume & issue
Vol. 13, no. 10
pp. 1 – 13

Abstract

Read online

Abstract X-linked lymphoproliferative disease (XLP) is either caused by loss of the SLAM-associated protein (SAP; XLP-1) or the X-linked inhibitor of apoptosis (XIAP; XLP-2). In both instances, infection with the oncogenic human Epstein Barr virus (EBV) leads to pathology, but EBV-associated lymphomas only emerge in XLP-1 patients. Therefore, we investigated the role of XIAP during B cell transformation by EBV. Using humanized mice, IAP inhibition in EBV-infected mice led to a loss of B cells and a tendency to lower viral titers and lymphomagenesis. Loss of memory B cells was also observed in four newly described patients with XIAP deficiency. EBV was able to transform their B cells into lymphoblastoid cell lines (LCLs) with similar growth characteristics to patient mothers’ LCLs in vitro and in vivo. Gene expression analysis revealed modest elevated lytic EBV gene transcription as well as the expression of the tumor suppressor cell adhesion molecule 1 (CADM1). CADM1 expression on EBV-infected B cells might therefore inhibit EBV-associated lymphomagenesis in patients and result in the absence of EBV-associated malignancies in XLP-2 patients.